4.6 Review

Vaccination of Immunocompromised Cats

Journal

VIRUSES-BASEL
Volume 14, Issue 5, Pages -

Publisher

MDPI
DOI: 10.3390/v14050923

Keywords

feline; immunocompromise; immunosuppression; immunodeficiency; vaccine; efficacy; safety; duration of immunity; DOI

Categories

Funding

  1. Boehringer Ingelheim (ABCD)
  2. Virbac
  3. IDEXX

Ask authors/readers for more resources

This article discusses the common condition of immunocompromised cats and the vaccination issues associated with it. It summarizes the available scientific studies and provides decision-making support for veterinarians.
Immunocompromise is a common condition in cats, especially due to widespread infections with immunosuppressive viruses, such as feline immunodeficiency virus (FIV) and feline leukaemia virus (FeLV), but also due to chronic non-infectious diseases, such as tumours, diabetes mellitus, and chronic kidney disease, as well as treatment with immunosuppressive drugs, such as glucocorticoids, cyclosporins, or tumour chemotherapy. In this review, the European Advisory Board on Cat Diseases (ABCD), a scientifically independent board of experts in feline medicine from eleven European countries, discusses the current knowledge and rationale for vaccination of immunocompromised cats. So far, there are few data available on vaccination of immunocompromised cats, and sometimes studies produce controversial results. Thus, this guideline summarizes the available scientific studies and fills in the gaps with expert opinion, where scientific studies are missing. Ultimately, this review aims to help veterinarians with their decision-making in how best to vaccinate immunocompromised cats.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available